According to the CDC, the prevalence of childhood obesity has almost quadrupled since the 1970s, from 5.2 percent to 19.3 percent among those aged 2 to 19
Some patients may require an even higher dose of 2 mg weekly for optimal effect, particularly for weight management indications, though this should be approached cautiously with careful monitoring for adverse effects
These medications, such as Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide, represent a significant advancement in the fight against obesity and its associated conditions like diabetes and heart disease
The monthly check-in appointments allow the patient and provider to adjust the dosage or their diet and exercise plan as necessary
Pick one-time, monthly, or quarterly when a product is eligible